help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published ahead of print on March 23, 2006, doi:10.1164/rccm.200509-1485OC

Am. J. Respir. Crit. Care Med., Volume 173, Number 12, June 2006, 1342-1347

A more recent version of this article appeared on June 15, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200509-1485OCv1
173/12/1342    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikegami, M.
Right arrow Articles by Whitsett, J. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikegami, M.
Right arrow Articles by Whitsett, J. A

Submitted on September 22, 2005
Accepted on March 23, 2006

Intratracheal Recombinant Surfactant Protein D Prevents Endotoxin Shock in the Newborn Preterm Lamb

Machiko Ikegami1*, Karen Carter2, Kimberly Bishop2, Annuradha Yadav2, Elizabeth Masterjohn2, William Brondyk2, Ronald K Scheule2, and Jeffrey A Whitsett1

1 Division of Pulmonary Biology, Cincinnati Children's Hospital, University of Cincinnati, Cincinnati, OH, USA, 2 Genzyme Corporation, Farmingham, MA, USA

* To whom correspondence should be addressed. E-mail: machiko.ikegami{at}cchmc.org.

Rationale:The susceptibility of neonates to pulmonary and systemic infection has been associated with the immaturity of both lung structure and the immune system. Surfactant Protein D is a member of the collectin family of innate immune molecules that plays an important role in innate host defense of the lung. Objectives: We tested whether treatment with recombinant human Surfactant Protein D influenced the response of the lung and systemic circulation to intratracheally administered E.coli Iipopolysaccharides. Methods:After intratracheal lipopolysaccharide instillation, preterm newborn lambs were treated with surfactant and ventilated for 5 hours. Measurement:Survival rate, physiological lung function, lung and systemic inflammation and endotoxin level in plasma were evaluated. Main Results:In control lambs, intratracheal Iipopolysaccharides caused septic shock and death associated with increased endotoxin in plasma. In contrast, all lambs treated with recombinant human Surfactant Protein D were physiologically stable and survived. Leakage of Iipopolysaccharides from the lungs to the systemic circulation was prevented by intratracheal recombinant human Surfactant Protein D. Recombinant human Surfactant Protein D prevented systemic inflammation and decreased the expression of IL-1{beta}, IL-8 and IL-6 in the spleen and liver. Likewise, recombinant human Surfactant Protein D decreased IL-1{beta} and IL-6 in the lung and IL-8 in the plasma. Recombinant human Surfactant Protein D did not alter pulmonary mechanics following endotoxin exposure. Recombinant human Surfactant Protein D was readily detected in the lung 5 hours after intratracheal instillation. Conclusions: Intratracheal recombinant human Surfactant Protein D prevented shock caused by endotoxin released from the lung during ventilation in the premature newborn.
Key words: Sepsis, Respiratory Distress Syndrome, Cytokines, Lung Compliance, Pulmonary Surfactant




This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
M. Ikegami, S. Grant, T. Korfhagen, R. K. Scheule, and J. A. Whitsett
Surfactant protein-D regulates the postnatal maturation of pulmonary surfactant lipid pool sizes
J Appl Physiol, May 1, 2009; 106(5): 1545 - 1552.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Gram, S. Yang, M. Steiner, A. Somani, S. Hawgood, B. R. Blazar, A. Panoskaltsis-Mortari, and I. Y. Haddad
Simultaneous absence of surfactant proteins A and D increases lung inflammation and injury after allogeneic HSCT in mice
Am J Physiol Lung Cell Mol Physiol, February 1, 2009; 296(2): L167 - L175.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Yamazoe, C. Nishitani, M. Takahashi, T. Katoh, S. Ariki, T. Shimizu, H. Mitsuzawa, K. Sawada, D. R. Voelker, H. Takahashi, et al.
Pulmonary Surfactant Protein D Inhibits Lipopolysaccharide (LPS)-induced Inflammatory Cell Responses by Altering LPS Binding to Its Receptors
J. Biol. Chem., December 19, 2008; 283(51): 35878 - 35888.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Dahl
Biomarkers for Chronic Obstructive Pulmonary Disease: Surfactant Protein D and C-Reactive Protein
Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1177 - 1178.
[Full Text] [PDF]

Home page
 Ther Adv Respir DisHome page
D. D. Sin, P. S. Pahlavan, and S.F. P. Man
Review: Surfactant protein D: A lung specific biomarker in COPD?
Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 65 - 74.
[Abstract] [PDF]

Home page
 ChestHome page
M. Ikegami, E. A. Scoville, S. Grant, T. Korfhagen, W. Brondyk, R. K. Scheule, and J. A. Whitsett
Surfactant Protein-D and Surfactant Inhibit Endotoxin-Induced Pulmonary Inflammation
Chest, November 1, 2007; 132(5): 1447 - 1454.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. B. Milbrandt, A. Ishizaka, and D. C. Angus
Update in Critical Care 2006
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 638 - 648.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society 		  SOTA, FL